Carla J. de Boer

Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

Pieter Sonneveld, Meletios Α. Dimopoulos, Mario Boccadoro et al. · New England Journal of Medicine · 2023 · 515 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Expression of Ep-CAM in normal, regenerating, metaplastic, and neoplastic liver

Carla J. de Boer, J. Han van Krieken, Connie M. Janssen‐van Rhijn et al. · The Journal of Pathology · 1999 · 236 citations

Medicine, Cell Biology, Pathology +17

Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study

Irene Braña, Antonio Calles, Patricia LoRusso et al. · Targeted Oncology · 2014 · 210 citations

Medicine, Oncology, Pharmacology +15

Mantle-cell lymphoma: a population-based clinical study.

Gerjo A. Velders, Hanneke C. Kluin‐Nelemans, Carla J. de Boer et al. · Journal of Clinical Oncology · 1996 · 189 citations

Medicine, Hematology, Oncology +15

Phase 2 Study of the Safety and Antitumor Activity of Apalutamide (ARN-509), a Potent Androgen Receptor Antagonist, in the High-risk Nonmetastatic Castration-resistant Prostate Cancer Cohort

Matthew R. Smith, Emmanuel S. Antonarakis, Charles J. Ryan et al. · European Urology · 2016 · 126 citations · Full text

Medicine, Oncology, Pharmacology +17